本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

4D Molecular Therapeutics

5.80
-0.2550-4.21%
成交量:27.01萬
成交額:157.07萬
市值:2.68億
市盈率:-1.82
高:6.02
開:5.97
低:5.70
收:6.05
資料載入中...
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/23

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/09/13

重要事件披露

Form 8-K - Current report
2023/08/12

SEC問詢函

Form CORRESP - Correspondence
2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/11

重要事件披露

Form 8-K - Current report
2023/06/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals